Medinex Valuation

Q: What is the Fair Price of OTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

OTX (SGD0.18) is trading below our estimate of [[fair value]] (SGD0.53)

Is OTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OTX (SGD0.18) is trading below our estimate of fair value (SGD0.53)

Significantly Below Fair Value: OTX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OTX?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for OTX. This is calculated by dividing OTX's market cap by their current preferred multiple.
What is OTX's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	S$24.02m

OTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.7x
Enterprise Value/EBITDA	29.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does OTX's PE Ratio compare to its peers?

The above table shows the PE ratio for OTX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.4x
MIJ Alliance Healthcare Group	40.3x	n/a	S$29.0m
NPL Niks Professional	11.2x	n/a	S$17.0m
FRQ Singapore Paincare Holdings	10.4x	n/a	S$20.5m
505 AsiaMedic	11.7x	n/a	S$13.9m
OTX Medinex	23.2x	n/a	S$24.0m

Price-To-Earnings vs Peers: OTX is expensive based on its Price-To-Earnings Ratio (23.2x) compared to the peer average (18.4x).

Price to Earnings Ratio vs Industry

How does OTX's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.1%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: OTX is expensive based on its Price-To-Earnings Ratio (23.2x) compared to the Asian Healthcare industry average (23.2x).

Price to Earnings Ratio vs Fair Ratio

What is OTX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OTX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	23.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OTX's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.